Skip to main content

Table 1 Characteristics of the CAD population (n = 1001).

From: Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an Observational Study

Age (years, mean (range))

62 (36-81)

Men/Women n (%)

783/218 (78/22)

Type 2 Diabetes Mellitus n (%)

200 (20)

Myocardial infarction n (%)

436 (44)

Hypertension n (%)

553 (56)

Metabolic syndrome n (%)

244 (24)

SBP (mmHg)

139.4 (19.3)

DBP (mmHg)

82.1 (9.7)

Current smokers n (%)

204 (20.4)

BMI (kg/m2)

27.9 (11.5)

Total cholesterol (mmol/L)

4.6 (1.0)

HDL cholesterol (mmol/L)

1.3 (0.4)

LDL cholesterol (mmol/L)

2.5 (0.8)

Triglycerides (mmol/L)

1.6 (1.1)

Fasting glucose (mmol/L)

6.0 (1.9)

IL-18 pg/mL

248.0 (195.3, 322.7)*

IL-18 BP pg/mL

23.2 (19.2, 28.2)*

HbA1c (%)

6.0 (0.9)

Medication %

 

   Statins

98

   Aspirin

100

   β-Blockers

76

   Nitrates

22

   ACE inhibitors

26

  1. Values are mean (SD) or number (proportions) if not otherwise stated
  2. SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; ACE: angiotensin converting enzyme.
  3. * Median levels (25- and 75 percentiles)